01 3Pfizer Canada Inc.
02 1Pfizer Canada ULC
01 22091663
02 22362481
01 4Anidulafungin
01 4Powder for Solution
01 22013-03-15
02 22020-03-02
Patent Expiration Date : 2013-03-15
Date Granted : 2007-10-30
Brand Name : ERAXIS
Patent Number : 2091663
Filing Date : 1993-03-15
Strength per Unit : 100mg/vial
Dosage Form : Powder for Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2013-03-15
Date Granted : 2007-10-30
Patent Expiration Date : 2020-03-02
Date Granted : 2008-11-04
Brand Name : ERAXIS
Patent Number : 2362481
Filing Date : 2000-03-02
Strength per Unit : 100mg/vial
Dosage Form : Powder for Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2020-03-02
Date Granted : 2008-11-04
Patent Expiration Date : 2013-03-15
Date Granted : 2007-10-30
Brand Name : ERAXIS
Patent Number : 2091663
Filing Date : 1993-03-15
Strength per Unit : 100 mg / Vial
Dosage Form : Powder for Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2013-03-15
Date Granted : 2007-10-30
Patent Expiration Date : 2020-03-02
Date Granted : 2008-11-04
Brand Name : ERAXIS
Patent Number : 2362481
Filing Date : 2000-03-02
Strength per Unit : 100 mg / Vial
Dosage Form : Powder for Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2020-03-02
Date Granted : 2008-11-04
LOOKING FOR A SUPPLIER?
